African-American MS Patients with and Without Early B-cell Repletion After Anti-CD20 Monoclonal Infusion Therapy Have Similarly Low Levels of Disease Activity (P10-1.009)
To compare disease activity in MS patients of African descent on anti-CD20 therapy with early B-cell repletion (‘early repletion’, ER) to patients without early B-cell repletion (‘normal repletion’, NR).
Authors
- Arnaldo Arbini (ORCID: https://orcid.org/0000-0003-0345-4174)
- Abhimanyu Amarnani (ORCID: https://orcid.org/0000-0001-9548-595X)
- Gregg J. Silverman (ORCID: https://orcid.org/0000-0001-9480-9457)
- Hannah Kopinsky
- Ilya Kister (ORCID: https://orcid.org/0000-0003-3549-949X)
- David Fenyö (ORCID: https://orcid.org/0000-0001-5049-3825)
- Angie Kim
Institutions
- Neurology, Inc (US)
- New York University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211568
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00